MRA Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $760K | Buy |
974
+109
| +13% | +$85K | 0.36% | 38 |
|
|
2025
Q1 | $714K | Sell |
865
-665
| -43% | -$549K | 0.38% | 35 |
|
|
2024
Q4 | $1.18M | Buy |
1,530
+351
| +30% | +$271K | 0.63% | 28 |
|
|
2024
Q3 | $1.04M | Sell |
1,179
-137
| -10% | -$121K | 0.57% | 27 |
|
|
2024
Q2 | $1.19M | Buy |
1,316
+140
| +12% | +$127K | 0.68% | 24 |
|
|
2024
Q1 | $915K | Buy |
1,176
+328
| +39% | +$255K | 0.55% | 26 |
|
|
2023
Q4 | $495K | Buy |
+848
| New | +$495K | 0.33% | 46 |
|